Related Posts
The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming
Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
This toolkit, comprised of fact sheets, worksheets, sample communications materials, and sample social media is designed to help aid how you support your own mental health journey, along with your community’s.
Just as banks have helped seniors bridge the digital divide and leverage online banking to better manage their money, healthcare organizations need to help older adults leverage digital technology to better manage their health.
NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
One in four Americans say they struggle to afford their prescription medications. The establishment of this Charitable Pharmacy in Milford will allow patients who live east of Cincinnati better access to care.
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Charitable Pharmacies of America organization member receives Health Equity grant
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
The pharmacy industry sees at least five changes